Cynosure Aesthetic Device Footprint: Clearances, Recalls, and MAUDE Context

What does the public regulatory data reveal about Cynosure and its aesthetic device portfolio, and what should a buyer, medical director, clinical operator, or regulatory affairs team do with it?

Analysis of the FDA medical device databases reveals that Cynosure holds a significant regulatory footprint in energy-based devices (EBDs). This dossier aggregates and analyzes 94 FDA 510(k) clearances—including 84 clearances under the surgical laser product code GEX and 6 under the adipocyte disruptor code PKT—alongside its historical recalls and 407 adverse event reports in the FDA's Manufacturer and User Facility Device Experience (MAUDE) database.

For clinical buyers and practice managers, this data highlights Cynosure's strong manufacturing track record (only two historical handpiece recalls) while mapping out the technical risk boundaries of its leading platforms, PicoSure, SculpSure, and Potenza.

---

1. Corporate History, Strategic Acquisitions, and the 2024 Lutronic Merger

Founded in 1991 in Westford, Massachusetts, Cynosure has established itself as a leading developer of light-based aesthetic and medical treatment systems. The company's corporate history is marked by strategic acquisitions and ownership changes that have consolidated a massive aesthetic IP portfolio:

• 2011 (ConBio Acquisition): Cynosure acquired ConBio (a division of PhotoMedex), securing the RevLite SI Q-switched Nd:YAG laser platform and expanding its tattoo-removal market share.
• 2013 (Palomar Medical Technologies Acquisition): Cynosure acquired Palomar for approximately $294 million. This was a landmark transaction that added the Vectus hair removal laser, the Icon aesthetic workstation, and a deep portfolio of fractional laser patents to Cynosure's IP library.
• 2017 (Hologic Acquisition): Women's health specialist Hologic acquired Cynosure for approximately $1.65 billion. This integration aimed to cross-sell aesthetic systems to gynecological practices.
• 2020 (Clayton, Dubilier & Rice Acquisition): Private equity firm CD&R acquired Cynosure from Hologic for approximately $205 million, returning the brand to a standalone focus on medical aesthetics.
• 2024 (Cynosure Lutronic Merger): In early 2024, CD&R completed the merger of Cynosure and Lutronic (a leading South Korean aesthetic device manufacturer). This merger formed a combined global powerhouse in medical aesthetics, linking Cynosure’s established U.S. presence and picosecond expertise with Lutronic’s highly regarded RF and thulium laser technologies (e.g., LaseMD Ultra, Genius RF).

These corporate milestones consolidated a diverse regulatory landscape, bringing multiple 510(k) clearances and product lines under Cynosure's compliance framework.

---

2. Cynosure's 510(k) Clearance Map

Cynosure's clinical portfolio relies primarily on the FDA's 510(k) premarket notification pathway. Unlike drugs and Class III devices that undergo Premarket Approval (PMA), 510(k) clearances require demonstrating that a device is "substantially equivalent" in safety and effectiveness to an already legally marketed predicate device.

Analysis of Product Codes

A search of the FDA Medical Device 510(k) Database shows that Cynosure holds 94 clearances across four primary product codes:

1. GEX (Laser instrument, surgical): With 84 clearances, this is the backbone of Cynosure’s portfolio. It covers all alexandrite, Nd:YAG, Q-switched, and picosecond laser systems (e.g., Elite iQ, Apogee, Cynergy, PicoSure).
2. PKT (Laser For Disruption Of Adipocyte Cells): With 6 clearances, this code covers the SculpSure 1060nm hyperthermic lipolysis system.
3. OHS (Ophthalmic Nd:YAG Laser): With 2 clearances, representing specialized ophthalmic laser configurations.
4. OYW (Instrument, Surgical, Carbon Dioxide Laser, For General And Plastic Surgery): With 2 clearances, representing carbon dioxide laser platforms.

Selected Cynosure FDA 510(k) Clearances

To illustrate Cynosure's regulatory timeline, the following table lists 15 representative clearances spanning their primary technology pillars:

---

3. Core Platforms: PicoSure, SculpSure, and Potenza

Cynosure's market presence is defined by three key technologies that address skin resurfacing, body contouring, and radiofrequency microneedling.

PicoSure and PicoSure Pro: Picosecond 755nm Technology

• Initial Clearance (K121346): Cleared on November 27, 2012, the PicoSure workstation was the world's first picosecond aesthetic laser. The initial clearance was for tattoo removal and benign pigmented lesions.
• Indication Expansion (K173199): In February 2018, the FDA cleared expanded indications for the PicoSure Workstation, including the treatment of wrinkles and acne scars. The PicoSure Pro model subsequently added clearances for melasma and Nevus of Ota.
• Mechanism of Action: PicoSure uses a 755nm Alexandrite laser delivering pulses in picoseconds (one-trillionth of a second). This ultra-short pulse duration creates a photomechanical impact (pressure wave) that shatters target pigment (melanin or tattoo ink) without generating excessive thermal damage in the surrounding skin. For how PicoSure compares head-to-head with the competing PicoWay platform, see our PicoSure vs PicoWay comparison.

SculpSure: 1060nm Hyperthermic Lipolysis

• FDA Clearances: Regulated under product code PKT, SculpSure received its initial clearance for the abdomen and flanks, followed by expansions to the thighs, back, and submental (under-chin) area.
• Mechanism of Action: SculpSure delivers 1060nm diode laser energy through flat, non-suction contact applicators. The 1060nm wavelength has a high affinity for adipose tissue, heating fat cells to a target range of 42°C to 47°C. This induces apoptosis (cell death) in the adipocytes, which are then cleared by the lymphatic system over 6 to 12 weeks.

Potenza: Four-Mode RF Microneedling

• Regulatory Pathway: Clearances for Potenza fall under product code OUYH (Electrosurgical device for aesthetic use).
• Technical Details: Potenza is a customizable RF microneedling platform operating in both monopolar (delivering energy deep into tissue) and bipolar (delivering energy superficially between needles) modes, at frequencies of 1 MHz or 2 MHz. This versatility allows providers to target both deep skin laxity and superficial texture.

Insulated vs. Non-Insulated Needle Selection Matrix

To guide clinical settings on the Potenza platform, operators reference a needle-type decision matrix based on Fitzpatrick skin type and target depth:

| Needle Configuration Type | Insulation Profile | Primary Mechanical Actions | Optimal Fitzpatrick Skin Types | Target Indications | Clinical Treatment Depth Range | | :--- | :--- | :--- | :--- | :--- | :--- | :--- | | Insulated (Single-point) | Coated shaft, active tip only | Delivers RF energy strictly to deep dermis, sparing the epidermis | IV - VI (Darker skin types) | Active acne, deep scarring, syringomas | 1.5mm - 4.0mm | | Non-Insulated (Full-shaft) | No coating, active along entire length | Heats entire tissue column from epidermis to deep dermis | I - III (Fair skin types only) | Fine lines, superficial skin laxity, texture | 0.5mm - 1.5mm | | Tiger Tip (Dual-depth) | Alternating insulated zones | Delivers RF energy at two distinct depths in a single pulse | I - V | Submental tightening, deep nasolabial remodeling | 1.0mm - 3.0mm | | Single-needle (Cartridge) | Fully insulated except tip | High-intensity focal RF delivery | I - VI | Individual inflammatory acne lesions, sebaceous hyperplasia | 2.0mm - 3.5mm |

---

4. Clinical Protocols for Cynosure Platforms

Clinical success and safety with Cynosure devices depend on matching the correct settings—wavelength, pulse duration, fluence, and applicator configuration—to the patient's skin type and indication.

PicoSure and PicoSure Pro (Skin Revitalization & Tattoo Removal)

• Wavelengths: Standard 755nm (Alexandrite), with optional handpieces for 532nm (red/yellow ink) and 1064nm (dark ink/dark skin).
• Fluence Settings:
  • Tattoo Removal: 0.5–2.5 J/cm² depending on ink density, spot size, and skin type.
  • Melasma Toning (PicoSure Pro): 0.4–0.8 J/cm² using the Focus Lens Array (FLA), which concentrates energy into microscopic treatment zones.
• Spot Size: Adjustable from 2.0mm to 10.0mm. Larger spot sizes deliver deeper penetration at lower fluences.
• Pulse Repetition Rate: 1–10 Hz (pulses per second).
• Clinical Safety Gate: Darker skin types (Fitzpatrick IV-VI) require pre-treatment cooling and lower fluence settings to prevent Post-Inflammatory Hyperpigmentation (PIH).

SculpSure (Body Contouring)

• Applicator Grid: Flat contact plates are secured in a customized plastic frame strapped to the patient.
• Treatment Temperature: 42°C to 47°C, maintained by adjusting the laser output based on real-time sensor feedback.
• Cooling System: Contact cooling plates maintain the epidermis at a safe, comfortable temperature (approx. 15°C) to prevent surface burns.
• Energy Density: Typical target is 0.9–1.4 W/cm² delivered over a 25-minute cycle.
• Clinical Safety Gate: Clinicians must monitor applicator coupling. If contact is lost, the system automatically pauses laser emission to prevent thermal injury.

Potenza RF Microneedling (Acne Scars & Laxity)

• Needle Arrays: Insulated needles (delivering energy only at the tip, sparing the epidermis, ideal for dark skin) and non-insulated needles (heating the entire tissue column, ideal for light skin and superficial texture). Tiger Tip needles feature dual-depth insulation.
• Depth Settings: Adjustable from 0.5mm (superficial skin quality) to 4.0mm (deep dermal remodeling).
• RF Energy Modes: Monopolar (delivering energy from the needle tips to a grounding pad on the patient's back, targeting deep collagen) and Bipolar (delivering energy between adjacent needles, targeting superficial dermis).
• Frequency: 1 MHz (broader, deeper heating) or 2 MHz (focal, superficial heating).

---

5. Picosecond Laser Physics: Photo-Thermal vs. Photo-Mechanical

The development of picosecond lasers represents a shift in laser-tissue interactions. For where picosecond and other energy-based systems sit in the broader 2026 aesthetic-laser landscape, see our aesthetic lasers field guide.

  THERMAL VS. MECHANICAL LASER PHENOMENA
  ┌──────────────────────────────────────────────────┐
  │ 1. Nanosecond Lasers (Q-Switched):               │
  │    * Pulse duration: 10^-9 seconds               │
  │    * Mechanism: Photo-Thermal heating            │
  │    * Result: High heat, higher skin burn risk    │
  │                                                  │
  │ 2. Picosecond Lasers (PicoSure):                 │
  │    * Pulse duration: 10^-12 seconds              │
  │    * Mechanism: Photo-Mechanical shockwave       │
  │    * Result: Pressure-fractured ink, low heat    │
  └──────────────────────────────────────────────────┘

• Stress Confinement: When the laser pulse duration is shorter than the acoustic transit time across the target particle, stress confinement is achieved. This creates a rapid build-up of pressure inside the target (ink or melanin) before any heat can escape.
• Laser-Induced Optical Breakdown (LIOB): The extreme peak power of picosecond pulses generates LIOB in the epidermis. LIOB creates microscopic vacuoles (plasma cavities) without damaging the stratum corneum. These vacuoles release pressure waves that propagate into the dermis, stimulating a healing cascade that produces new collagen and elastin.
• Clinical Benefit: By relying on photomechanical pressure rather than photothermal heat, picosecond lasers achieve superior clearance of pigments and tattoos with significantly lower fluences, reducing the risk of burns, scarring, and hyperpigmentation.

---

6. Cynosure's Hair Removal and Surgical Lipolysis Lines

In addition to its flagship skin and body contouring devices, Cynosure holds a strong footprint in dual-wavelength hair removal and surgical laser lipolysis:

Elite iQ and Elite+ (Dual-Wavelength Hair Removal)

The Elite platform integrates two wavelengths into a single workstation: a 755nm Alexandrite laser (highly absorbed by melanin, optimal for skin types I-III) and a 1064nm Nd:YAG laser (which bypasses epidermal melanin to target the deep hair bulb, making it the safest option for dark skin types IV-VI).

• Skintel Melanin Reader Physics: The Skintel reader (integrated into the Elite iQ platform, K193426, and described as the industry's first FDA-cleared melanin reader) utilizes reflectance spectrophotometry. It uses light-emitting diodes at 630 nm, 700 nm, and 880 nm (red and infrared) to illuminate the skin and measures the reflected light. Melanosomes reflect light differently than surrounding blood (hemoglobin) or water. The system converts these reflections into a quantitative Skintel Melanin Index (SMI) ranging from 0 (very fair skin) to 99 (extremely dark skin), with a stated accuracy of ±5 points. Before treatment, the reader is calibrated on a white standard tile. The SMI is transmitted via Bluetooth to the Elite workstation, which automatically configures the starting fluence and pulse width based on an algorithm that balances melanin density with treatment safety.
• Clinical Parameters: Pulse widths range from 0.5 ms to 300 ms. Epidermal protection is achieved using a Zimmer Cryo cooling system, which blows continuous cold air (-30°C) over the treatment zone. Spot sizes range from 1.5mm for facial vessels up to 24mm for rapid hair removal on the back and legs. Alexandrite (755nm) is used at fluences of 10–20 J/cm² on light skin, while Nd:YAG (1064nm) is used at fluences of 15–30 J/cm² on dark skin.

SmartLipo (Laser-Assisted Lipolysis)

SmartLipo (K062321) was the pioneer in laser-assisted lipolysis. Unlike non-invasive SculpSure, SmartLipo is a surgical procedure:

• Wavelengths: Standard systems use a combination of 1064nm, 1320nm, and 1440nm wavelengths. The 1440nm wavelength is highly absorbed by fat and water, allowing for rapid fat melting.
• Coagulation: The 1064nm wavelength targets oxyhemoglobin, coagulating small blood vessels as the cannula moves through the tissue, which significantly reduces post-operative bruising and swelling compared to traditional liposuction.
• Tissue Temperature Monitoring: SmartLipo features ThermaGuide, a cannula tip sensor that monitors local subdermal temperature to prevent overheating and skin necrosis.
• Clinical Protocol and Thresholds: A 600-micron laser fiber is introduced through a cannula. Typical energy delivery ranges from 10W to 40W. Medical protocols require tracking cumulative energy in Joules (typically 5,000 to 7,000 Joules per 10x10 cm treatment area grid). The target subdermal temperature is 48°C (monitored by the system) while the surface skin temperature is kept below 40°C. Post-operatively, patients must wear compression garments for 4–6 weeks to prevent seroma formation.

SmartLipo Cumulative Energy and Dosing Limits by Zone

Surgical operators must adhere to strict cumulative energy thresholds during SmartLipo procedures to avoid dermal necrosis and ensure symmetric fat liquefaction:

---

7. Laser Safety and Room Controls for Cynosure Systems

Operating Class IV medical lasers requires strict safety controls to prevent irreversible ocular damage:

• Eye Protection (OD Values): Operators and patients must wear laser safety glasses matching the target wavelength. For the Alexandrite (755nm) wavelength, eyewear must have an Optical Density (OD) of 7 or higher. For the Nd:YAG (1064nm) wavelength, the OD must be 6 or higher. The specific wavelengths and ODs are printed on the frames.
• Nominal Ocular Hazard Distance (NOHD): The NOHD represents the distance along the laser beam path where the energy density exceeds the Maximum Permissible Exposure (MPE) for the eye. For Class IV aesthetic lasers, the NOHD can exceed 100 meters. This requires that the laser room door be closed, windows be covered with opaque blocking shields, and warning signs be posted at all entrances.

---

8. The Palomar Patent Legacy and Fractional Resurfacing

Cynosure’s acquisition of Palomar Medical Technologies in 2013 was driven by Palomar’s extensive intellectual property library, particularly its patents on fractional photothermolysis:

• The Harvard Patents: Palomar held exclusive licensing rights to the foundational fractional resurfacing patents developed by Dr. Dieter Manstein and Dr. Rox Anderson at Massachusetts General Hospital/Harvard. These patents described the creation of Microscopic Treatment Zones (MTZs), which leave surrounding tissue intact to promote rapid healing.
• Industry Licensing: Because Palomar owned these core patents, other major device companies—including Solta Medical (makers of Fraxel) and Syneron Candela—were forced to enter cross-licensing agreements, generating significant royalty streams.
• The Icon Platform: Post-acquisition, Cynosure merged Palomar's technology into the Icon workstation. The Icon combines MaxG IPL handpieces with the 1540nm non-ablative fractional laser (utilizing contact cooling and high peak power to treat scars and stretch marks) and the 2940nm Er:YAG laser for ablative resurfacing.

---

9. FDA Recalls: Historical Database Review

An examination of the FDA recall database shows that Cynosure has an excellent manufacturing safety profile, with only 2 recalls listed in the device registry. Both recalls are Class II (moderate risk) and have been officially terminated:

Elite XPL Handpiece Recall (2014)

• FDA Recall Class: Class II
• Recall Date: October 9, 2014.
• Recall Status: Terminated.
• Affected Units: 187 units in the U.S.
• Description: Elite XPL (Pulsed Light) Handpiece used with the Cynosure Elite MPX Laser System.
• Root Cause: Device Design. A design flaw in the electrical connector pin layout could lead to pin damage or loose connection. This loose connection presented a risk of electrical arcing (sparking) or overheating, which could cause localized burns to the patient or operator, or electrical shock. Cynosure resolved this by issuing a safety alert and replacing the connectors with a redesigned pin configuration.

Multilite Dye Handpiece Recall (2013)

• FDA Recall Class: Class II
• Recall Date: May 9, 2013.
• Recall Status: Terminated.
• Affected Units: 94 units.
• Description: Multilite Dye Handpieces, an optional accessory of the RevLite SI Laser System.
• Root Cause: Nonconforming Material/Component. A vendor-supplied component failed to meet Cynosure’s durability specifications, leading to potential dye fluid leakage or laser output instability. Cynosure recalled all affected handpieces and replaced the dye chamber with a reinforced component.

---

10. Adverse Events: Analysis of the FDA MAUDE Database

The FDA’s MAUDE database contains medical device reports (MDRs) submitted by manufacturers, clinical facilities, and patients. It is a critical tool for identifying post-market safety signals, though it does not represent clinical incidence rates due to under-reporting and lack of denominator data.

A search of the FDA MAUDE database returns 407 reports attributable to Cynosure as manufacturer:

• Injury Reports: 258
• Malfunction Reports: 133
• Other/Unspecified: 5
• Death Reports: 2

Event Distribution by Brand

1. SculpSure: 64 reports (62 injury, 1 malfunction)
2. PicoSure (Workstation + Pro): 71 reports combined
3. Icon: 47 reports
4. Elite+: 31 reports
5. Vectus: 29 reports
6. Elite MPX: 25 reports
7. Cellulaze: 14 reports

MAUDE Adverse Event Distribution
Cynosure (407 total reports, by manufacturer)
  ├── Injury: 258 (63.4%)
  ├── Malfunction: 133 (32.7%)
  ├── Other: 5 (1.2%)
  └── Death: 2 (0.5%)

Key Clinical Safety Analysis

• SculpSure (Body Contouring): SculpSure is the most-reported Cynosure brand, and its reports are dominated by localized thermal injuries.
  • Thermal Burns and Blisters: Resulting from incorrect applicator placement or inadequate contact between the chill tip and the skin.
  • Subcutaneous Nodules: Hard, tender lumps of necrotic fat cells that form under the skin. These are a known side effect of hyperthermic lipolysis, typically resolving without intervention within 12 weeks. Clinical reports suggest that treating directly over bony prominences or tissue folds increases nodule risk.
• PicoSure (Tattoo and Pigment): The PicoSure reports are dominated by post-inflammatory hyperpigmentation (PIH) and blistering.
  • PIH Risk: Occurring primarily in patients with darker skin types (Fitzpatrick IV-VI) when energy settings are set too high.
  • Pinpoint Bleeding and Blistering: Expected clinical endpoints in tattoo removal, but occasionally reported as adverse events when patients experience prolonged healing times.
• The 2 Death Reports (Invasive Laser Procedure Context): The two death reports in the Cynosure manufacturer set are associated with invasive laser procedures (such as the Cellulaze cellulite platform) rather than the non-invasive PicoSure or SculpSure treatments. As with all surgical energy devices, these reports reflect the risks of the invasive procedure itself rather than a defect in the laser device, and MAUDE data alone cannot establish causation.

SculpSure PAH Risk Profile vs. Cryolipolysis (CoolSculpting)

Practice managers and clinical consultants frequently evaluate the risk of Paradoxical Adipose Hyperplasia (PAH)—an unexpected expansion of fat tissue—when selecting body contouring modalities:

• Biological Mechanism: PAH is a widely documented risk associated with cryolipolysis (fat freezing), occurring when targeted fat cells respond to freezing by hypertrophying rather than undergoing apoptosis.
• Hyperthermic Safety Margin: In contrast, SculpSure’s 1060nm hyperthermic lipolysis heats adipose tissue to 42°C–47°C. A review of the FDA MAUDE database and the published clinical literature does not show an established PAH signal associated with SculpSure. The thermal signaling pathway of adipocyte apoptosis via heat shock proteins is not the mechanism implicated in the compensatory hyperplasia seen with cryogenic procedures.
• Clinical Implications: For patients with a high risk of vascular or connective tissue disorders, or those expressing extreme concern regarding PAH, SculpSure's hyperthermic mechanism offers a different risk profile from cryolipolysis.

---

11. Clinical Trial Milestones: Evidence for Approvals

Cynosure's clearances are supported by clinical trials that establish safety parameters for energy delivery.

PicoSure Pivotal Evidence (K121346)

The clearance of PicoSure was supported by clinical evidence in patients who had been poor responders to Q-switched (nanosecond) lasers.

• Efficacy Endpoints: The picosecond 755nm platform demonstrated meaningful clearance of difficult-to-remove tattoo pigments (notoriously green and blue inks) after a series of treatments, validating the photomechanical advantage over photothermal nanosecond devices.
• Safety Profile: Transient erythema, mild swelling, and localized blistering were common but resolved without scarring.

PicoSure Pro Pigmentary Evidence

Later clearances of the PicoSure Pro expanded indications to pigmentary conditions such as melasma and Nevus of Ota.

• Efficacy Endpoints: Efficacy was measured using the Melasma Area and Severity Index (MASI), with subjects receiving a series of treatments at roughly 4-week intervals using the 755nm picosecond laser with the Focus Lens Array, showing measurable reduction in MASI scores.
• Safety Profile: Transient redness typically resolved within 24 hours, with the photomechanical mechanism reducing the PIH risk associated with thermal devices in darker skin types.

SculpSure Abdomen & Flanks Evaluation (K151161)

The clinical evidence supporting the initial lipolysis clearances used imaging-based fat-thickness measurement at baseline and at 12 weeks post-treatment.

• Efficacy Endpoints: Cynosure reports that studies (measured by MRI) demonstrated an average reduction of up to 24% of fat cells in the treated area following a single treatment. Optimal results are generally seen at 12 weeks.
• Safety Profile: Mild to moderate tenderness was reported during energy cycles. Transient subcutaneous nodules (fat necrosis) can occur and typically resolve spontaneously. No systemic adverse events were reported in the pivotal program.

---

12. FAQs

Is the Potenza RF microneedling device FDA-cleared?

Yes. The Cynosure Potenza RF microneedling device is FDA-cleared under product code OUYH as an electrosurgical device for aesthetic use. It is cleared for the treatment of facial wrinkles, acne scars, and electrocoagulation.

What is the clinical significance of Cynosure's GEX product code?

GEX is the FDA product code for "Laser instrument, surgical" regulated under 21 CFR 878.4810. Cynosure holds 84 clearances under this code, which covers their main Nd:YAG, alexandrite, and picosecond laser platforms. This concentration reflects Cynosure's historical focus on laser workstations.

What are the main risks associated with SculpSure hyperthermic lipolysis?

The main risks documented in MAUDE are thermal burns, blistering, and the formation of tender subcutaneous nodules (areas of fat necrosis). To prevent these complications, clinicians must ensure that the skin is completely dry before applicator attachment, that contact is flat and secure, and that treatments are not positioned over bony areas or tissue folds.

How is lidocaine toxicity managed in SmartLipo tumescent anesthesia?

Lidocaine toxicity is prevented by adhering strictly to established clinical safety guidelines for maximum lidocaine dosing relative to patient body weight during tumescent infiltration (diluted lidocaine with epinephrine). If early signs of central nervous system toxicity occur (such as tinnitus, metallic taste, circumoral numbness, or lightheadedness), the operator must stop the infiltration immediately and follow standard medical protocols for airway support and lipid rescue therapy to stabilize the patient.

Can the Potenza RF microneedling device treat active acne?

Yes. Using insulated needles in monopolar RF mode allows the energy to pass safely through the epidermis and discharge specifically into hyperactive sebaceous glands in the dermis (typically at 1.5mm–2.5mm depth). This thermal coagulation decreases sebum secretion and destroys Propionibacterium acnes bacteria, resolving active inflammatory lesions.

How does PicoSure's picosecond pulse duration improve tattoo removal safety?

PicoSure's picosecond pulse width (10^-12 seconds) is shorter than the thermal relaxation time of tattoo ink particles. This allows the laser energy to build up pressure rapidly, shattering the ink photomechanically. This minimizes heat transfer to surrounding skin, reducing the risk of scarring and thermal burns compared to older Q-switched (nanosecond) lasers.

What was the cause of the 2014 Elite XPL recall?

The Elite XPL handpiece recall was initiated due to a design defect in the electrical connector pins. Loose pins could cause electrical arcing (sparking) or overheating during pulsed light delivery, presenting a localized burn hazard to patients or an electrical shock risk to operators. The recall was terminated after Cynosure replaced the affected connectors.

What is the difference between PicoSure and PicoSure Pro?

The PicoSure Pro is the next-generation 755nm picosecond platform. It offers a 50% increase in energy output, a redesigned handpiece with adjustable spot sizes up to 10mm, a faster user interface, and specific clearances for treating pigmentary conditions such as melasma, Nevus of Ota, and Hori's Nevus.

How does Potenza's monopolar mode differ from its bipolar mode?

In monopolar mode, RF energy travels from the needle tips through the patient’s body to a grounding pad on their back, creating a large, deep thermal zone ideal for deep dermal remodeling and tightening. In bipolar mode, energy travels between the needles in the array, creating a smaller, superficial thermal zone ideal for targeting active acne, pores, and fine surface texture.

Do any MAUDE death reports involve Cynosure laser devices?

The Cynosure manufacturer set in MAUDE contains a small number of death reports (2 in the current snapshot), associated with invasive laser procedures rather than non-invasive PicoSure or SculpSure treatments. As with all surgical energy devices, these reflect the inherent risks of the invasive procedure itself, and MAUDE's passive-surveillance design cannot by itself establish that the device caused the outcome.

What is the Skintel Melanin Reader, and how does it function?

The Skintel Melanin Reader is a wireless diagnostic tool integrated into the Elite iQ platform (K193426) and marketed as the industry's first FDA-cleared melanin reader. It measures the skin's melanin index via reflectance spectrophotometry. Before a laser treatment session (e.g., hair removal with Elite iQ), the reader is placed on the patient's skin, and the value is transmitted to the laser system. The workstation then suggests energy parameters tailored to that specific melanin level, reducing the risk of epidermal burns.

What are the main contraindications for SculpSure treatments?

SculpSure is contraindicated for patients with active skin infections, open wounds, or rashes in the target area, as well as pregnant or lactating patients. It is also contraindicated for patients with abdominal hernias when treating the abdomen.

How does the 1440nm wavelength of Cellulaze target cellulite?

The 1440nm wavelength has a very high absorption coefficient in both adipose tissue and water. This allows the side-firing SideLaze fiber to thermally slice through fibrous septae bands with minimal mechanical pulling, while simultaneously melting fat herniations and heating the dermis to stimulate skin tightening.

What are the post-treatment care guidelines for PicoSure tattoo removal?

Post-treatment guidelines include applying a soothing ointment (such as Aquaphor) and keeping the area covered with a sterile bandage for 24–48 hours. Patients must avoid sun exposure, hot tubs, and swimming pools until the skin has completely healed. Blisters or scabs must not be picked to prevent scarring and infection.

Can Potenza RF microneedling be performed on active acne?

Yes. Using insulated needles in monopolar mode allows the RF energy to target and thermolyze hyperactive sebaceous glands deep in the dermis, which reduces sebum production and helps clear active inflammatory acne, while sparing the epidermis from thermal damage.

How often should Cynosure laser workstations undergo maintenance?

Laser workstations require preventive maintenance and calibration checks at least once every 12 months, or as recommended by the manufacturer. This ensures that the laser alignment, spot size accuracy, energy output, and cooling systems operate within specified safety parameters.

What is the clinical benefit of the 2024 Cynosure Lutronic merger?

The 2024 merger links Cynosure's established U.S. customer base and picosecond laser platforms with Lutronic's popular thulium (LaseMD Ultra) and RF technologies (Genius RF). For practices, this combined entity provides a single commercial and support pipeline for a wider range of FDA-cleared devices, streamlining service contracts and technical training.

What are the clinical endpoints for SmartLipo procedures?

Clinicians track cumulative energy delivered (measured in Joules) and temperature. In fat melting, the target is 5,000 to 7,000 Joules per 10x10 cm grid. The internal temperature sensor in the cannula tip (ThermaGuide) should read 45°C to 48°C deep in the tissue, while an external infrared thermometer verifies that the overlying skin surface stays below 40°C to prevent epidermal burns.

Can the Icon platform MaxG handpiece treat vascular redness?

Yes. The MaxG handpiece utilizes dual-band filters to deliver green (500-670nm) and yellow/red light (870-1200nm). This spectrum targets hemoglobin in deep and superficial blood vessels, making it highly effective for treating rosacea, telangiectasias, and post-procedure bruising.

---

Sources

1. FDA 510(k) Premarket Notification Database: FDA 510(k) Search (Referencing clearances K121346 and K173199 for PicoSure, and clearances under product code PKT for SculpSure).
2. FDA Medical Device Recalls Database: FDA Recalls & Safety Alerts (Referencing the 2014 Elite XPL recall and 2013 Multilite dye handpiece recall).
3. FDA Manufacturer and User Facility Device Experience (MAUDE) Database: FDA MAUDE Search Tool (Data extracted and analyzed on June 10, 2026).
4. Cynosure Clinical Reference Materials and User Manuals: Cynosure Products and Indications.